XTX Topco Ltd bought a new stake in shares of IO Biotech, Inc. (NASDAQ:IOBT – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & … [+2575 chars]...
Read moreNEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, toda… [+4593 chars]...
Read morePreclinical data further support the potential of dual-antigen and TGF--directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity NEW YORK, April 25, 2025 (GLOBE NEWSWIRE… [+5056 chars]...
Read more